A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

NCT03417245 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Hemophilia B

Interventions

DRUG: fitusiran
DRUG: factor concentrates

Sponsor

Genzyme, a Sanofi Company